Filing Details

Accession Number:
0001209191-23-041344
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-05 19:47:10
Reporting Period:
2023-07-03
Accepted Time:
2023-07-05 19:47:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1650131 Peter Radovich C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-07-03 1,425 $25.65 37,675 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.